D.E. Shaw & Co Portfolio holdings
D. E. Shaw & Co., L.P., founded in 1988 by David E. Shaw, a former Columbia University computer science professor, is a New York City-based global investment management firm renowned for pioneering quantitative investing, managing over $70 billion in assets as of late 2024. Starting with $28 million from Paloma Partners and private investors, the firm employs sophisticated mathematical models and proprietary algorithms—initially developed by a team of scientists and programmers—to exploit market anomalies across public and private markets, including equities, fixed income, and alternatives. Headquartered above a Greenwich Village bookstore in its early days, it now boasts over 2,500 employees across offices in North America, Europe, and Asia, led by a seven-member Executive Committee since Shaw stepped back in 2001 to focus on D. E. Shaw Research. Despite setbacks like the 1998 Russia debt crisis and the 2008 financial downturn, the firm has maintained a reputation for analytical rigor, risk management, and innovation, balancing its computational roots with discretionary strategies.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$345M |
| 2 |
Biogen
BIIB
|
+$281M |
| 3 |
Bausch Health
BHC
|
+$244M |
| 4 |
SPDR Gold Trust
GLD
|
+$238M |
| 5 |
Coca-Cola
KO
|
+$206M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
LyondellBasell Industries
LYB
|
+$397M |
| 2 |
AGN
Allergan Inc
AGN
|
+$374M |
| 3 |
TWC
TIME WARNER CABLE INC NEW COM STK
TWC
|
+$347M |
| 4 |
Microsoft
MSFT
|
+$265M |
| 5 |
IBM
IBM
|
+$251M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Energy | 9.69% |
| 2 | Consumer Discretionary | 9.53% |
| 3 | Technology | 9.28% |
| 4 | Healthcare | 8.29% |
| 5 | Financials | 8.06% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2551
PUT
Accenture
ACN
$101B
| $974K | ﹤0.01% |
10,400
-68,600
| -87% | -$6.12M |
|
2552
CALL
Archer Daniels Midland
ADM
$40.1B
| $967K | ﹤0.01% |
20,400
-20,000
| -50% | -$952K |
|
2553
Avient
AVNT
$3.41B
| $967K | ﹤0.01% |
25,886
-17,154
| -40% | -$651K |
|
2554
Century Aluminum
CENX
$4.35B
| $966K | ﹤0.01% |
+70,000
| New | +$1.41M |
|
2555
PUT
MasTec
MTZ
$24.7B
| $965K | ﹤0.01% |
50,000
-27,900
| -36% | -$558K |
|
|
FRSH
2556
DELISTED
Papa Murphy's Holdings, Inc
FRSH
| $964K | ﹤0.01% |
53,143
+5,903
| +12% | +$81K |
|
2557
California Water Service
CWT
$3.14B
| $963K | ﹤0.01% |
39,303
-14,813
| -27% | -$366K |
|
|
POZN
2558
DELISTED
POZEN INC
POZN
| $963K | ﹤0.01% |
124,793
+24,715
| +25% | +$180K |
|
2559
Acacia Research
ACTG
$447M
| $962K | ﹤0.01% |
89,827
+69,671
| +346% | +$909K |
|
|
SEM
2560
DELISTED
Select Medical
SEM
| $962K | ﹤0.01% |
120,365
-885,652
| -88% | -$6.62M |
|
2561
Acadia Pharmaceuticals
ACAD
$4.45B
| $960K | ﹤0.01% |
29,449
-144,752
| -83% | -$4.98M |
|
2562
Q2 Holdings
QTWO
$3.71B
| $959K | ﹤0.01% |
45,343
+15,814
| +54% | +$312K |
|
|
TCF
2563
DELISTED
TCF Financial Corporation Common Stock
TCF
| $957K | ﹤0.01% |
30,521
-17,351
| -36% | -$520K |
|
2564
New Mountain Finance
NMFC
$668M
| $956K | ﹤0.01% |
65,477
+45,611
| +230% | +$669K |
|
|
BT
2565
DELISTED
BT Group plc (ADR)
BT
| $954K | ﹤0.01% |
+29,292
| New | +$966K |
|
2566
LXP Industrial Trust
LXP
$3.53B
| $951K | ﹤0.01% |
+19,355
| New | +$1.05M |
|
2567
Travere Therapeutics
TVTX
$5.2B
| $951K | ﹤0.01% |
39,700
-5,900
| -13% | -$90K |
|
2568
Wayfair
W
$12.5B
| $951K | ﹤0.01% |
29,601
-19,729
| -40% | -$490K |
|
2569
TG Therapeutics
TGTX
$8.4B
| $950K | ﹤0.01% |
+61,346
| New | +$929K |
|
|
RGC
2570
DELISTED
Regal Entertainment Group
RGC
| $950K | ﹤0.01% |
41,605
-67,546
| -62% | -$1.5M |
|
|
HSNI
2571
DELISTED
HSN, Inc.
HSNI
| $950K | ﹤0.01% |
13,920
+1,779
| +15% | +$125K |
|
2572
CALL
CSX Corp
CSX
$94.2B
| $947K | ﹤0.01% |
85,800
-46,200
| -35% | -$531K |
|
2573
Philips
PHG
$24.8B
| $946K | ﹤0.01% |
48,174
+2,910
| +6% | +$58K |
|
2574
CALL
Agios Pharmaceuticals
AGIO
$2.14B
| $943K | ﹤0.01% |
10,000
| – | – |
|
|
2575
PUT
Agios Pharmaceuticals
AGIO
$2.14B
| $943K | ﹤0.01% |
10,000
| – | – |
|
Similar funds
D.E. Shaw & Co's Q1 2015 Portfolio in Review
As of Q1 2015, D.E. Shaw & Co held 4,408 positions worth $65.3B, down 16% from $77.8B the previous quarter. Its ten largest holdings account for 11% of the portfolio.
D.E. Shaw & Co withdrew a net $15B in Q1 2015, closing 828 positions and reducing 1,784 holdings. Its most notable exit was Allergan Inc, an estimated $374M position sold in full.
By sector, the portfolio is most concentrated in Energy at 9.7% of assets, up from 8% a quarter earlier, followed by Consumer Discretionary and Technology.
Against the trend, D.E. Shaw & Co opened a new position in SPDR Gold Trust worth $231M.
- D.E. Shaw & Co's largest Q1 2015 buy was SPDR Gold Trust: 2,033,000 shares worth $231M.
- D.E. Shaw & Co added most to State Street SPDR S&P 500 ETF Trust in Q1 2015, an estimated $345M increase.
- D.E. Shaw & Co's biggest Q1 2015 reduction was LyondellBasell Industries, cutting an estimated $397M.
- D.E. Shaw & Co fully exited Allergan Inc in Q1 2015, selling an estimated $374M.
- D.E. Shaw & Co's ten largest holdings make up 11% of its $65.3B portfolio in Q1 2015.
- D.E. Shaw & Co opened 448 new positions and closed 828 in Q1 2015.
- D.E. Shaw & Co's portfolio value fell 16% quarter-over-quarter to $65.3B.
Based on D.E. Shaw & Co's 13F filing for Q1 2015, filed 15 May 2015.